Most gastrointestinal side effects occur during dose escalation and reduce significantly over time
Trajectoire type : Poids dpart : 92 kg Phase 1 (12 mois Wegovy) : -16 kg 76 kg (17% perte) Arrt traitement (contrainte budgtaire) Phase 2 (12 mois post-arrt) : +10 kg 86 kg Pattern observ (donnes STEP 4 bras placebo) : Mois 1-3 post-arrt : Poids stable Mois 4-6 : Retour apptit progressif Mois 7-12 : Regain acclr (fringales, portions augmentes) Regain mdian : 62,5% du poids perdu (10 kg sur 16 kg) Leon STEP 4 : Wegovy = traitement chronique
Appetite Regulation GLP-1 tells your brain you feel full, helping reduce overeating
This does not affect statutory rights where goods are faulty, damaged, supplied incorrectly or not as described
Seibt TM, Proneth B, Conrad M (2019) Role of GPX4 in ferroptosis and its pharmacological implication
Product integrity, storage conditions, and handling procedures should be reviewed in accordance with applicable laboratory protocols and manufacturer guidance